TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Natumin Pharma AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 65,733 | 62,169 | 59,233 |
Financial expenses | 513 | 383 | 236 |
Earnings before taxes | -3,997 | -8,038 | -10,009 |
EBITDA | -2,600 | -6,144 | -8,091 |
Total assets | 54,904 | 51,392 | 44,749 |
Current assets | 37,651 | 33,508 | 25,630 |
Current liabilities | 23,228 | 20,683 | 7,543 |
Equity capital | 19,565 | 23,563 | 26,869 |
- share capital | 2,000 | 2,000 | 2,000 |
Employees (average) | 23 | 24 | 25 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 35.6% | 45.8% | 60.0% |
Turnover per employee | 2,858 | 2,590 | 2,369 |
Profit as a percentage of turnover | -6.1% | -12.9% | -16.9% |
Return on assets (ROA) | -6.3% | -14.9% | -21.8% |
Current ratio | 162.1% | 162.0% | 339.8% |
Return on equity (ROE) | -20.4% | -34.1% | -37.3% |
Change turnover | 3,564 | 2,936 | 4,829 |
Change turnover % | 6% | 5% | 9% |
Chg. No. of employees | -1 | -1 | 2 |
Chg. No. of employees % | -4% | -4% | 9% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.